Health Sciences, Biomedicine and Bioengineering

Axolotl Axolotl

© TU Dresden

Axolotl

© TU Dresden

Health Sciences, Biomedicine and Bioengineering comprises three interconnected fields at the interface of basic and translational research:

  • Stem Cells and Tissue Formation, which directly leads to Regenerative Therapies (CRTD, Excellence Cluster);
  • research uncovering the causes of, and developing therapeutic approaches for, major diseases of modern societies, i.e. Cancer (OncoRay), Diabetes (DZD), and Neurodegeneration (DZNE) as well as other disorders of the brain, notably those tackled by the Psychological and Behavioral Sciences; and
  • Molecular Bioengineering, which provides an interface between biology and engineering (B CUBE, BIOTEC, Max Bergmann Center of Biomaterials).

In addition to these three established fields, an emerging research area is Systems Biology, where experimental and theoretical science meet. A particular strength of this RPA is the transdisciplinary networking of basic and translational researchers within TUD and its local non-university partners such as the MPI of Molecular Cell Biology and Genetics. These research foci constitute a fertile ground for the advancement of young researchers, as exemplified by the Dres-den International Graduate School for Biomedicine and Bioengineering (DIGS-BB), awarded in the 1st program phase of the Excellence Initiative.

Examples of the reseach excellence for the priority area:

  • DFG Research Center and Cluster of Excellence: 

    Center for Regenerative Therapies Dresden - CRTD

    and the  Exczellence-Cluster "From cells to tissues to therapies: Engineering the cellular basis of regeneration"

  • SFB 655 "Cells into tissues: stem cell and progenitor commitment and interactions during tissue formation"
  • Neuroscience and functional disorders of the brain: The TU Dresden is one of the partner locations of the German Center for Neurodegenerative Diseases (DZNE).
  • DFG Collaborative Research Centre (CRC) “Volition and Cognitive Control”. (SFB 940)
  • Translational cancer research: The Dresden center OncoRay is one of six “Centers for Innovation Competence” funded by the German Federal Ministry of Education and Research.

  • The Paul-Langerhans-Institute of the TU Dresden is one of the locations of the German Center for Diabetes Research within the Helmholtz Association. Furthermore, there are two DFG- Research Groups (KFO 252 "Microenvironment of the Adrenal in Health and Disease", FOR 1586 "SKELMET – Mesenchymal and Osteogenic Signalling Pathways in Malignant Bone Diseases") in the field of Endocrinology.
  • BMBF- Center for Innovation Competence B-CUBE, the Biotechnology Center (BIOTEC) of the TU Dresden and the Max-Bergmann-Center of Biomaterials
  • Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB)
  • SFB/TRR 67 "Functional Biomaterials for Controlling Healing Processes in Bone and Skin - From Material Science to Clinical Application" with integrated graduate school (Leipzig, Dresden), SFB/TRR 79 "Materials for tissue regeneration within systemically altered bone" (Gießen, Heidelberg, Dresden), SFB/TRR 83 "Molecular Architecture and Cellular Functions of Lipid/Protein Assemblies" (Heidelberg, Bonn, Dresden), SFB/TRR 127 "

    Biology of xenogeneic cell and organ transplantation - from bench to bedside" (München, Hannover, Dresden)

  • Graduate Schools: European Graduate School in Addiction Research (Volkswagenstiftung), International Max Planck Research School for Molecular Cell, Developmental and Systems Biology (Max-Planck-Gesellschaft)
  • SPP 1384 "Mechanism of Genome Haploidization" (coordinated by TU Dresden)
  • DFG (clinical) Research Groups: KFO 247 "Deep brain stimulation.
    Mechanisms of action, Cortex-Basal Ganglia-Physiology and Therapy Optimization.", KFO 249 "Defects of the innate immune system in autoinflammatory and autoimmune diseases", KFO 252 "Microenvironment of the Adrenal in Health and Disease", FOR 1586 "Mesenchymal and Osteogenic Signalling Pathways in Malignant Bone Diseases"
  • FOR 1617:  Learning and Habitisation as Predictors of the Development and Maintenance of Alcoholism - LeAD

  • FOR 2033: The Hematopoietic Niches

  • FOR 1961: Mature T-cell Lymphomas - mechanisms of perturbed clonal T-cell homeostasis.

  • FOR 1756: Functional dynamics of cell contracts in cellular assemblies and migratory cells.

  • Humboldt-Professur: Jochen Guck
  • ERC Advanced Investigator Grant: Elly Tanaka
  • ERC Advanced Investigator Grant: Michael Brand
  • ERC Starting Grant: Dr. Jörg Mansfeld
  • Freigeist Fellow (VW-Foundation): Dr. Volker Busskamp
  • ERC Starting Grant: Dr. Volker Busskamp
  • ERC Starting Grant: Prof. Stephan Grill

About this page

Sacha Hanig
Last modified: Mar 15, 2016